SCHEMBL7046543

SCHEMBL7046543

O=C(Cc1ccc(Cl)cc1)c1cc(O)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 7/20 0.58
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
GPR35 Q9HC97 2/20 0.49
ABCC3 O15438 1/20 0.49
ABCC4 O15439 1/20 0.49
NR1I2 O75469 1/20 0.49
ABCB11 O95342 1/20 0.49
NR3C1 P04150 1/20 0.49
PGR P06401 1/20 0.49
HTR1A P08908 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
RARB P10826 1/20 0.49
COMT P21964 1/20 0.49
SLC6A2 P23975 1/20 0.49
ADORA1 P30542 1/20 0.49
ADRA1A P35348 1/20 0.49
PTGS2 P35354 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KCNH2 Q12809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046444 0.89 TTR (0.51) TTRRAB9ANPC1GPR35ABCC3
SCHEMBL7045653 0.86 TTR (0.67) TTRRAB9ANPC1GPR35ABCC3
SCHEMBL7048659 0.86 TTR (0.52) TTRRAB9AGPR35ABCC3ABCC4
Nebicapone SCHEMBL29379610 0.86 TTR (0.56) TTRRAB9AGPR35ABCC3ABCC4
Nebicapone SCHEMBL132167 0.86 TTR (0.56) TTRRAB9AGPR35ABCC3ABCC4
SCHEMBL7198182 0.84 CRHBP (0.52) TTRRAB9AGPR35ABCC3ABCC4
SCHEMBL7048651 0.82 TTR (0.48) TTRRAB9AGPR35ABCC3ABCC4
SCHEMBL7046272 0.82 TTR (0.53) TTRRAB9ANPC1GPR35ABCC3
SCHEMBL7046913 0.81 TTR (0.50) TTRRAB9ANPC1GPR35ABCC3
SCHEMBL7243523 0.81 TTR (0.54) TTRRAB9AGPR35ABCC3ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP claimed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US claimed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP claimed
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed